(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Degeneration Saline group presented with significant decreased final weight in relation to other groups. حسب Flavia Gomes Velasque Gama (21175112)

The number, age, and weight of the patients with cleft lip and palate in the velar adhesion VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

Significant inter-relationships between baseline variables and MSCC or MCS. حسب Harshit Arora (22008280)

الموضوعات:

Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. حسب Mieke L. M. Bentvelzen (21594442)

"…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA.…"

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. حسب Mieke L. M. Bentvelzen (21594442)

"…The red line represents the significance threshold (<i>P < </i>5 × 10⁻⁸). …"

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. حسب Ziyue Liu (381532)

The table shows the significant and non-significant altered group with different parameters. حسب Ashraf Attia Mahmoud (21262201)

الموضوعات:

National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. حسب Luke R. Cavanah (19022435)

الموضوعات:

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically significant (<i>p</i> < 0.05) and non-significant (p > 0.05) values. حسب Oswaldo Maillard (20660661)

SBP3 KD decreases the surface localization of VESA-1. حسب Atefeh Fathi (7370876)

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات: